Detalhe da pesquisa
1.
Prognostic factors for disease activity in newly diagnosed teriflunomide-treated patients with multiple sclerosis: a nationwide Danish study.
J Neurol Neurosurg Psychiatry;
2024 Apr 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38569873